Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Inspire Medical Systems (INSP) EBIT Margin (2017 - 2026)

Inspire Medical Systems' EBIT Margin history spans 10 years, with the latest figure at 0.55% for Q1 2026.

  • On a quarterly basis, EBIT Margin rose 19.0% to 0.55% in Q1 2026 year-over-year; TTM through Mar 2026 was 5.61%, a 32.0% decrease, with the full-year FY2025 number at 5.59%, up 109.0% from a year prior.
  • EBIT Margin hit 0.55% in Q1 2026 for Inspire Medical Systems, down from 17.14% in the prior quarter.
  • Over the last five years, EBIT Margin for INSP hit a ceiling of 17.14% in Q4 2025 and a floor of 23.14% in Q1 2022.
  • Historically, EBIT Margin has averaged 3.08% across 5 years, with a median of 0.74% in 2025.
  • Biggest five-year swings in EBIT Margin: surged 1583bps in 2024 and later tumbled -413bps in 2025.
  • Tracing INSP's EBIT Margin over 5 years: stood at 0.24% in 2022, then skyrocketed by 2088bps to 4.83% in 2023, then surged by 175bps to 13.3% in 2024, then rose by 29bps to 17.14% in 2025, then crashed by -103bps to 0.55% in 2026.
  • Business Quant data shows EBIT Margin for INSP at 0.55% in Q1 2026, 17.14% in Q4 2025, and 4.3% in Q3 2025.